Meeting
2023 ASCO Annual Meeting
Investigating racial inequities of circulating tumor DNA (ctDNA) use in patients with non-small cell lung cancer: A real world analysis.
Authors
Angelica D'Aiello
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
Angelica D'Aiello , Hiba Narvel , Ayse Ece Cali Daylan , Eleftheria Atalla , Sindhu Vikash , Sheila Solomon , Jianyou Liu , Xiaonan Xue , Balazs Halmos , Haiying Cheng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9133)
DOI
10.1200/JCO.2023.41.16_suppl.9133
Abstract #
9133
Poster Bd #
121
Abstract Disclosures
Similar Posters
Poster
2019 Breakthrough
An optimized ultra-deep massively parallel sequencing with unique molecular identifier tagging for detection and quantification of circulating tumor DNA from lung cancer patients.
First Author: Hong-Anh Thi Pham
Poster
2023 ASCO Breakthrough
CRISPincette, and detection of low frequency cancer mutations in ctDNA.
First Author: Jin-Soo Kim
Poster
2023 ASCO Annual Meeting
ctDNA detection in patients with brain metastases arising from solid tumors.
First Author: Laura Alder
Poster
2022 ASCO Annual Meeting
Prevalence of incidental pathogenic germline variants detected in cfDNA in patients with oncogene-driven non-small cell lung cancer.
First Author: Laura Mezquita